• Wpływ reformy zdrowotnej w Stanach Zjednoczonych ObamaCare na biznes farmaceutyczny

Wpływ reformy zdrowotnej w Stanach Zjednoczonych ObamaCare na biznes farmaceutyczny

DOI: https://doi.org/10.19195/2084-4093.22.4.3
Łukasz Jasiński
Google Scholar Łukasz Jasiński
Marta Makowska
Google Scholar Marta Makowska
Publikacja:

Ekonomia Tom 22 Nr 4 (2016)

Strony od 35 do 45

Abstrakt

Impact of the Healthcare Reform in the United States ObamaCare on the Pharmaceutical Business

ObamaCare changes have different influence on diverse healthcare business. Pharmaceutical industry seems to gain on this reform unlike the insurance business. In this article we briefly present the main positive and negative effects of health reform in the US. Then, we point to the impact of ObamaCare on profits, costs and activities of pharmaceutical companies. We discuss changes such as: increase in sales of prescription drugs; new rules of registration of generic drugs; novel tax on sales of original drugs; incentives for pharma to put more attention to specific fields in R&D; bigger transparency in relations between physicians and pharma industry.

Pobierz artykuł PDF

Zamierzasz pobrać artykuł darmowy. Tutaj znajdziesz informacje o zasadach pobierania darmowych artykułów z bazy.